DAXISPHARMA
ActiveSummary
DAXISPHARMA has been active since 1980 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6.0m and a net result of €166,396. Equity remains stable across the filed fiscal years (±1.9% per year). Its solvency ranks better than 26% of 5071 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability29▼-3
Solvency49▼-15
Growth58=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €260,000 at 30 days acceptable
Liquidity tight (current ratio 1.31 against 1.54 in 2024; short-term debt: 76.3% and cash: 0.6% of total assets), and 76.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
23.7%
Return on assets
0.7%
Age of the figures
12 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-03-2026, 51 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
51 d early
2024
34 d early
2023
15 d early
2022
22 d late
2021
2 d early
2020
30 d early
2019
61 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 7 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 16 April (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 close30-09-2026 today30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€166,396▼ 18.7%
2024 · €204,594
Working capital
€5.9m▲ 12.1%
2024 · €5.3m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€301,214-€218,362▼ 27.5%€313,038▲ 43.4%€242,284▼ 22.6%€254,287▲ 5.0%
Net result€126,578within the sector's middle half-€46,885within the sector's middle half▼ 63.0%€220,488within the sector's middle half▲ 370%€204,594within the sector's middle half▼ 7.2%€166,396within the sector's middle half▼ 18.7%
Equity€6.3mabove the sector's middle half€6.5mabove the sector's middle half▲ 3.5%€6.1mabove the sector's middle half▼ 6.1%€6.0mabove the sector's middle half▼ 2.2%
Total assets€19.0mabove the sector's middle half-€17.3mabove the sector's middle half▼ 9.0%€14.2mabove the sector's middle half▼ 18.2%€15.8mabove the sector's middle half▲ 11.2%€25.2mabove the sector's middle half▲ 59.9%
Debt€12.8m-€11.0m▼ 13.7%€7.7m▼ 30.5%€9.7m▲ 25.8%€19.2m▲ 99.3%
Working capital€5.2mabove the sector's middle half-€5.3mabove the sector's middle half▲ 2.3%€5.6mabove the sector's middle half▲ 5.3%€5.3mabove the sector's middle half▼ 5.7%€5.9mabove the sector's middle half▲ 12.1%
Solvency36.3%within the sector's middle half45.9%within the sector's middle half▲ 9.6pp38.8%within the sector's middle half▼ 7.1pp23.7%within the sector's middle half▼ 15.1pp
Current ratio1.40within the sector's middle half-1.48within the sector's middle half▲ 0.071.73within the sector's middle half▲ 0.251.54within the sector's middle half▼ 0.181.31within the sector's middle half▼ 0.24
Return on assets (ROA)0.7%below the sector's middle half-0.3%below the sector's middle half▼ 0.4pp1.6%within the sector's middle half▲ 1.3pp1.3%within the sector's middle half▼ 0.3pp0.7%within the sector's middle half▼ 0.6pp
Staff (FTE)41above the sector's middle half-40above the sector's middle half▼ 2.4%41.7above the sector's middle half▲ 4.3%44.1above the sector's middle half▲ 5.8%43.9above the sector's middle half▼ 0.5%
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 5% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €25.2m
Fixed assets
€96,521 ▼ 88.9%
Current assets
€25.1m ▲ 68.6%
Equity and liabilities €25.2m
Equity
€6.0m ▼ 2.2%
Debt
€19.2m ▲ 99.3%
Debt's share of the balance-sheet total rises from 61.2% to 76.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€355,008▲
2024 · €352,072
Cash flow
€267,117▼
2024 · €314,382
Quick ratio
1.27▼
2024 · 1.54
Debt to equity
3.21▲
2024 · 1.58
ROE
2.8%▼
2024 · 3.3%
Interest coverage
1.09▼
2024 · 1.36
Debt ≤ 1 year
€19.2m▲
2024 · €9.7m
Income taxes
€185,239▲
2024 · €181,400
Staff costs
€6.6m▲
2024 · €6.3m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 4,681 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 97% are still going.
- Small
- 20 years or older
- solvency 10 to 30%
- a profit under 5% of the balance sheet
1.1%
went bankrupt
2.0%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 4,681 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €69,604 | €17,439 | - | - | €290 | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | €1.6m | €1.5m | - | - |
| Remuneration, social security and pensions62 | €4.9m | €5.0m | €5.4m | €6.3m | €6.6m | ▲ 3.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €190,012 | €162,111 | €142,524 | €109,788 | €100,721 | ▼ 8.3% |
| Other operating charges640/8 | €126,018 | €109,532 | €148,194 | €159,086 | €143,901 | ▼ 9.5% |
| Gross operating margin9900 | €5.6m | €5.5m | €6.0m | €6.9m | €7.1m | ▲ 3.1% |
| Operating profit (loss)9901 | €301,214 | €218,362 | €313,038 | €242,284 | €254,287 | ▲ 5.0% |
| Financial income75/76B | - | €2,570 | €251,074 | €402,734 | €423,810 | ▲ 5.2% |
| Recurring financial income75 | - | €2,570 | €251,074 | €402,734 | €423,810 | ▲ 5.2% |
| Financial charges65/66B | €42,757 | €44,208 | €185,322 | €259,025 | €326,463 | ▲ 26.0% |
| Recurring financial charges65 | €42,757 | €44,208 | €185,322 | €259,025 | €326,463 | ▲ 26.0% |
| Profit (loss) for the period before taxes9903 | €258,457 | €176,725 | €378,790 | €385,994 | €351,635 | ▼ 8.9% |
| Income taxes67/77 | €131,879 | €129,840 | €158,302 | €181,400 | €185,239 | ▲ 2.1% |
| Profit (loss) for the period9904 | €126,578 | €46,885 | €220,488 | €204,594 | €166,396 | ▼ 18.7% |
| Profit (loss) for the period to be appropriated9905 | €126,578 | €46,885 | €220,488 | €204,594 | €166,396 | ▼ 18.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €19.0m | €17.3m | €14.2m | €15.8m | €25.2m | ▲ 59.9% |
| Fixed assets21/28 | €1.1m | €1.0m | €942,889 | €867,681 | €96,521 | ▼ 88.9% |
| Intangible fixed assets21 | - | €3,246 | €1,080 | €0 | - | - |
| Tangible fixed assets22/27 | €1.1m | €1.0m | €941,809 | €867,681 | €96,521 | ▼ 88.9% |
| Land and buildings22 | €960,490 | €926,937 | €867,003 | €806,806 | - | - |
| Plant, machinery and equipment23 | €95,058 | €22,235 | €18,582 | €15,489 | - | - |
| Furniture and vehicles24 | €15,303 | €48,971 | €52,475 | €45,386 | €90,763 | ▲ 100.0% |
| Other tangible fixed assets26 | - | - | - | - | €5,758 | - |
| Assets under construction and advance payments27 | €10,100 | €3,750 | €3,750 | - | - | - |
| Financial fixed assets28 | €1,000 | - | - | - | - | - |
| Current assets29/58 | €18.0m | €16.3m | €13.2m | €14.9m | €25.1m | ▲ 68.6% |
| Stocks and contracts in progress3 | - | - | - | - | €766,382 | - |
| Stocks30/36 | - | - | - | - | €766,382 | - |
| Amounts receivable within one year40/41 | €1.8m | €1.3m | €2.0m | €2.6m | €1.6m | ▼ 37.0% |
| Trade receivables40 | €65,195 | €90,575 | €49,480 | €291 | €1.6m | ▲ 559,008% |
| Other amounts receivable41 | €1.8m | €1.2m | €1.9m | €2.6m | €18,332 | ▼ 99.3% |
| Current investments50/53 | €9.3m | €8.8m | €11.0m | €10.6m | €22.5m | ▲ 112% |
| Cash at bank and in hand54/58 | €6.8m | €6.3m | €265,572 | €1.7m | €149,955 | ▼ 90.9% |
| Deferred charges and accrued income490/1 | €44,358 | €33,071 | €18,093 | €37,310 | €40,077 | ▲ 7.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €19.0m | €17.3m | €14.2m | €15.8m | €25.2m | ▲ 59.9% |
| Equity10/15 | - | €6.3m | €6.5m | €6.1m | €6.0m | ▼ 2.2% |
| Contributions10/11 | €5.6m | €5.6m | €5.6m | €5.6m | €5.6m | = |
| Capital10 | €5.6m | €5.6m | €5.6m | €5.6m | €5.6m | = |
| Issued capital100 | €5.6m | €5.6m | €5.6m | €5.6m | €5.6m | = |
| Reserves13 | €267,475 | €269,818 | €280,843 | €291,073 | €299,392 | ▲ 2.9% |
| Non-distributable reserves130/1 | €267,475 | €269,818 | €280,843 | €291,073 | €299,392 | ▲ 2.9% |
| Legal reserve130 | €267,475 | €269,818 | €280,843 | €291,073 | €299,392 | ▲ 2.9% |
| Profit (loss) carried forward14 | €370,321 | €414,862 | €624,325 | €218,689 | €76,766 | ▼ 64.9% |
| Amounts payable17/49 | €12.8m | €11.0m | €7.7m | €9.7m | €19.2m | ▲ 99.3% |
| Amounts payable within one year42/48 | €12.8m | €11.0m | €7.7m | €9.7m | €19.2m | ▲ 99.3% |
| Financial debts43 | €10.7m | €9.4m | €5.9m | €7.2m | €16.7m | ▲ 132% |
| Other loans439 | €10.7m | €9.4m | €5.9m | €7.2m | €16.7m | ▲ 132% |
| Trade debts44 | €942,915 | €383,045 | €506,353 | €225,400 | €183,618 | ▼ 18.5% |
| Suppliers440/4 | €942,915 | €383,045 | €506,353 | €225,400 | €183,618 | ▼ 18.5% |
| Taxes, remuneration and social security45 | €1.2m | €1.2m | €1.1m | €1.4m | €1.8m | ▲ 26.6% |
| Taxes450/3 | €161,508 | €169,302 | €173,880 | €206,308 | €552,474 | ▲ 168% |
| Remuneration and social security454/9 | €1.0m | €1.1m | €964,929 | €1.2m | €1.2m | ▲ 1.9% |
| Other amounts payable47/48 | - | - | €169,969 | €834,269 | €604,725 | ▼ 27.5% |
| Accrued charges and deferred income492/3 | €6,240 | - | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €126,578 | €46,885 | €220,488 | €204,594 | €166,396 | ▼ 18.7% |
| + Depreciation and write-downs630 | €190,012 | €162,111 | €142,524 | €109,788 | €100,721 | ▼ 8.3% |
| Operating cash flow (approximation) | €316,590 | €208,995 | €363,012 | €314,382 | €267,117 | ▼ 15.0% |
| Investment in fixed assets (approximation) | - | -€85,299 | -€80,274 | -€34,579 | €670,438 | ▲ 2,039% |
| Change in cash | - | -€539,117 | -€6.0m | €1.4m | -€1.5m | ▼ 208% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-08
State Gazette act
RestructuringMerger · Shareholding · Board composition36 facts ▸
State Gazette act
Restructuring
Merger · Shareholding · Board composition36 facts ▸
- Merger, fusion simplifiée, intégralité du patrimoine, tant activement que passivement
- Shareholding, Servier Benelux, SA
- Shareholding, Servier Benelux, SA
- Shareholding, Servier Benelux, SA
- Board composition, Ziad MATTA (managing director)
- Board composition, SERVIER NEDERLAND B.V. (director)
- Board composition, ARTS ET TECHNIQUES DU PROGRES, SAS (director)
- Board composition, Ziad MATTA (managing director)
- Board composition, François VILETTE (director)
- Board composition, Stéphane MASCARAU (director)
- Board composition, Ziad MATTA (managing director)
- Board composition, François VILETTE (director)
- +24 further facts in this act
10-06
State Gazette act
Reappointments: Ziad Matta, Stéphane Mascarau and François VilettePower of attorney7 facts ▸
State Gazette act
Reappointments: Ziad Matta, Stéphane Mascarau and François Vilette
Power of attorney7 facts ▸
- General meeting, 04-03-2026
- Power of attorney, Coralie-Anne Tilleux
- Power of attorney, Luus Hillen
- Power of attorney, ebl redsky
- Director reappointment, Ziad Matta (managing director)
- Director reappointment, Stéphane Mascarau (director)
- Director reappointment, François Vilette (director)
24-03
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 03/02/2026
- Registered-office move, Chaussée de Mons 1424, 1070 Bruxelles (Anderlecht)
10-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
27-03
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
15-04
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-09
Financial
Highest result since 2021net €220,488 ▲370%
Operating result €313,038, net result €220,488, both a record.
22-05
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 22 days late
2022
30-09
Financial
Weakest financial yearnet €46,885 ▼63%
Net result drops to €46,885, the lowest in the series; recovery starts the following year.
28-04
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-03
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
30-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 61 days late
Show earlier events
2019
25-04
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
16-04
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
16-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 16 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
3 of 28 acts read
About the unread acts
Of the 28 Belgian State Gazette acts we know for this company, 3 have been read. The other 25 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
under verification, last change in 2026
This board is reconstructed from a single act (26073986). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Board 2
François Vilette
CurrentDirector · since 04-03-2026
Stéphane Mascarau
CurrentDirector · since 04-03-2026
Day-to-day management 1
Ziad Matta
CurrentManaging director · since 04-03-2026
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
25 of this company's 28 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 1980
Ground area
4.1 ha
Building footprint
8,740 m²
Volume, LiDAR
183,051 m³
2 parcels, Brussels · tallest building 32.2 m, ±9 floors. Linked by address, not a title deed.
17
companies at this address
See who is registered here
1 establishment unit
DAXISPHARMA
since 19802.017.871.994
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21306D0005/00P000 | Brussels | 3.5 ha | 1 · 6,370 m² | 32.2 m · 9 fl. |
| 21306D0091/00D000 | Brussels | 6,236 m² | 1 · 2,370 m² | 18.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
3 people since 2026, 3 in office
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| François Vilette |
|
| Stéphane Mascarau |
|
| Ziad Matta |
|
Articles of association
Purpose
Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe ou indirecte avec la fabrication, le conditionnement, la…
Full purpose (4 activities)
- Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe ou indirecte avec la fabrication, le conditionnement, la distribution, la publicité et le commerce en général de tous produits pharmaceutiques, chimiques, cosmétiques, diététiques, vétérinaires et ménagers, tous dispositifs médicaux et tous articles et tout matériel servant à l'emballage et au conditionnement des produits cités, la publicité en général, le courtage et la coopération en matière de publicité
- L'exploitation directe ou indirecte de tous brevets, marques de fabrique, marques de commerce, procédés de fabrication et autres droits de propriété industrielle; l'acquisition, l'obtention, la cession ou la rétrocession, la licence ou la sous-licence, de tous brevets, marques, dénominations, procédés et autres droits; toutes recherches, études, améliorations et inventions en relation directe ou indirecte avec les objets précités
- Faire toutes acquisitions, négociations, ventes, échanges, dépôts, livraisons, expéditions, facturations et recouvrements, toutes opérations de commission, de mandat ou d'agence en général, ainsi que toutes opérations mobilières et immobilières en relation directe ou indirecte avec son objet ou de nature à faciliter, favoriser ou développer son commerce et son industrie
- Étendre son activité et acquérir des intérêts dans toutes entreprises industrielles, civiles ou commerciales, dont l'objet serait similaire ou en relation avec son propre objet ou dont la nature serait en mesure de faciliter, favoriser ou développer ses propres activités et même fusionner avec elles; elle peut leur apporter toute aide technique, commerciale ou financière et participer à leur gestion et administration; elle peut se constituer garant ou aval de tous engagements souscrits ou à souscrire par les sociétés ou entreprises dans lesquelles elle a un intérêt direct ou indirect
Structure & network
Owners and holdings
5 ownersChain of control
- Servier Benelux
- DAXISPHARMA
Highest known parent: Servier Benelux. The sources do not say who stands above it.
Owners 5
- Servier Beneluxparent100%
- BIOFARMAFRparentSourceown accounts 30-09-202599.57%
- Servier Nederland BVNLSourceown accounts 30-09-20250.18%
- Servier Luxembourg SALUSourceown accounts 30-09-20250.14%
-
0.06%
Holdings 0
The accounts to 30-09-2025 list no holdings, and no other source names one.
According to the annual accounts to 30-09-2025 of DAXISPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
3 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Acquisitions and mergers
1 transactionTaken over by:SERVIER BENELUX, SA
Capital and shareholders
Shareholders according to the acts
Stated in the act
act of 03-08-2026 ↗
- Servier Benelux, SA (BE 0408.056.927) all shares
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Similar companies · same sector, comparable size
Crocodile
BE 0405.325.782
Kortrijk · Eq €5,961,601
PUGH & CO INTERNATIONAL
BE 0403.086.171
Mont-Saint-Guibert · Eq €6,075,994
NorrDia Belgium
BE 0542.825.064
Tienen · Eq €5,865,183
B. BRAUN MEDICAL
BE 0407.089.994
Machelen (Brab.) · Eq €5,816,802
TOBUFAR
BE 0464.486.973
Ukkel · Eq €5,784,991
Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 544 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded29-08-1980
Fiscal year end30-09
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID
0208:0420720276
Also
9925:BE0420720276
Registered
14-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.